FY2025 · period end Dec '25 · from the 10-K filed Mar 30, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross Profit | $0.00B | $0.00B | — | — | — |
| Operating Income | negative: -$0.01B | negative: -$0.00B | negative: -$0.00B | negative: -$0.00B | — |
| Net Income | negative: -$0.01B | negative: -$0.00B | negative: -$0.00B | negative: -$0.00B | — |
| EPS (Diluted) | negative: -$0.11 | negative: -$0.02 | negative: -$0.01 | negative: -$0.01 | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $0.03B | $0.00B | $0.00B | $0.00B | — |
| Total Liabilities | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Stockholders' Equity | $0.03B | $0.00B | $0.00B | negative: -$0.00B | negative: -$0.00B |
| Cash & Equivalents | — | — | — | — | — |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | negative: -$0.00B | negative: -$0.00B | negative: -$0.00B | negative: -$0.00B | — |
| Capital Expenditures | $0.00B | $0.00B | — | — | — |
| Free Cash Flow | negative: -$0.00B | negative: -$0.00B | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — |
| Operating Margin | negative: -0.9% | negative: -0.2% | — | — | — |
| Net Margin | negative: -0.9% | negative: -0.1% | — | — | — |
| Return on Equity | negative: -35.4% | negative: -32.5% | negative: -1.3% | 81.1% | — |
| Return on Assets | negative: -31.6% | negative: -48.1% | negative: -1723.6% | negative: -9472.3% | — |
| Debt / Equity | — | — | — | — | — |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001213900-26-095806 | Feb 23, 2026 | Aug 31, 2026 | Aug 31, 2026 21:25 UTC | EDGAR |
| 10-Q | 0001918080-26-000016 | Jun 30, 2026 | Aug 7, 2026 | Aug 6, 2026 23:03 UTC | EDGAR |
| 8-K | 0001918080-26-000014 | Aug 6, 2026 | Aug 6, 2026 | Aug 6, 2026 11:40 UTC | EDGAR |
| 8-K | 0001213900-26-081585 | Jul 23, 2026 | Jul 27, 2026 | Jul 27, 2026 12:30 UTC | EDGAR |
| 8-K | 0001213900-26-069596 | Jun 16, 2026 | Jun 17, 2026 | Jun 17, 2026 19:45 UTC | EDGAR |
| 10-Q | 0001918080-26-000012 | Mar 31, 2026 | May 15, 2026 | May 15, 2026 15:56 UTC | EDGAR |
| 8-K | 0001918080-26-000008 | May 14, 2026 | May 14, 2026 | May 14, 2026 11:02 UTC | EDGAR |
| 8-K | 0001213900-26-041229 | Apr 7, 2026 | Apr 8, 2026 | Apr 8, 2026 10:11 UTC | EDGAR |
Direct links to SEC EDGAR. DBHL has additional filings available on the SEC site.
Who is buying and selling Deep Isolation Nuclear, Inc. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on DBHL yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on DBHL and publish the result to your public profile.
Ask about Deep Isolation Nuclear, Inc.
Continue in Workspace — cited answers on DBHL, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs